There isn't specific information available about FGF1 (Fibroblast Growth Factor 1) trial results for Parkinson's disease treatment in the current resources. However, there is related and exciting research happening around growth factor therapies for Parkinson's that's worth knowing about.
A protein called GDNF (Glial Cell Show Full Answer
There isn't specific information available about FGF1 (Fibroblast Growth Factor 1) trial results for Parkinson's disease treatment in the current resources. However, there is related and exciting research happening around growth factor therapies for Parkinson's that's worth knowing about.
A protein called GDNF (Glial Cell Line Derived Neurotrophic Factor) has been studied in a similar way — delivering growth factors directly to the brain to try to restore damaged dopamine-producing cells. Results have been promising but mixed, and researchers believe further trials are needed. For the most up-to-date information on FGF1 trials specifically, these steps are recommended:
- Ask your neurologist or movement disorder specialist — they'll have the most current clinical trial information
- Check ClinicalTrials.gov — a free, searchable database of ongoing and completed trials
- Visit the Michael J. Fox Foundation website — they track emerging Parkinson's research closely
It's always best to discuss any clinical trial interest with your doctor before pursuing participation.
May 14
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
